Forward Citations = 24

Loading Chart...

5 inventors (with patents filed for the assignee):

Ernst Nitsch (4 out of 5 patents)

Dieter Binder (2 out of 35 patents)

Gerhard Greier (2 out of 4 patents)

4. Harald Forster (2 out of 2 patents)

5. Fatima Asskali (2 out of 2 patents)

6 patents: Sort by Forward Citations

1. 5561226 - Process for the production of a pyrogen-free fructan which is readily (1996-10-01),

2. 5470841 - Metabolizable plasma substitute (1995-11-28),

3. 5436232 - Pharmaceutical composition for peritoneal dialysis (1995-07-25),

4. 5424302 - Process for the production of starch degradation products with a narrow (1995-06-13),

5. 5352692 - Thiophene-2-carboxylic acid derivatives (1994-10-04),

6. 4994484 - 1-(3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl)-3-phenyl-1-propanones (1991-02-19),

Company Overview

Laevosan-gesellschaft M.b.h. is a leading pharmaceutical company specializing in the development and production of high-quality natural supplements and herbal remedies. With a focus on innovation and sustainability, Laevosan-gesellschaft is committed to providing safe and effective products to improve the health and well-being of its customers. Through research and collaboration with experts in the field, the company aims to continuously expand its product range and bring cutting-edge solutions to the market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#27 in Linz

#461 in Austria

Linz, Austria

Laevosan-Gesellschaft M.b.h.

Forward Citations = 24

5 inventors:

Ernst Nitsch (4 out of 5 patents)

Dieter Binder (2 out of 35 patents)

Gerhard Greier (2 out of 4 patents)

4. Harald Forster (2 out of 2 patents)

5. Fatima Asskali (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Laevosan-Gesellschaft M.b.h.. Retrieved from https://idiyas.com/company/laevosan-gesellschaft-m-b-h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]